CARE Ratings Ltd
CARE Ratings Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on CARE Ratings Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Consolidated Operating Income for Q1 FY27: Rs. Standalone Q1 FY27: - Operating Income: Rs.
From CARE Ratings Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Consolidated Operating Income for Q1 FY27: Rs. 111.68 Cr, up 18.9% YoY (Page 2, 13)
- Standalone Operating Income: Rs. 88.15 Cr, up 16.5% YoY (Page 2, 13)
- Consolidated Ratings Business Revenue: Rs. 98.71 Cr, up 19.1% YoY (Page 2, 13)
- Consolidated Non-Ratings Business Revenue: Rs. 12.97 Cr, up 17.9% YoY (Page 2, 13)
- EBITDA consolidated: Rs. 34.63 Cr, up 24.2% YoY; standalone Rs. 32.09 Cr, up 18.2% YoY (Page 2, 13)
- PAT consolidated: Rs. 32.99 Cr, up 24.6% YoY; standalone Rs. 33.88 Cr, up 16.3% YoY (Page 2, 13)
2 more points management made on revenue & sales performance
Profitability & Margins
See what CARE Ratings Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Capital Markets
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what CARE Ratings Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
CARE Ratings Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹131 Cr, net profit ₹53 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What CARE Ratings Ltd's management said in earlier quarters
- Q1 FY25 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q4 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY22 earnings call →
- Q2 FY22 earnings call →
- Q4 FY20 earnings call →
- Q2 FY20 earnings call →
- Q1 FY20 earnings call →
- Q4 FY19 earnings call →
Others in Capital Markets this season
- ICRA Ltd (Q1 FY27)
Revenue for Q1 FY2027: INR 163.4 crore, up from INR 124.5 crore in Q1 FY2026 (31.2% YoY growth). Key concall takeaways from ICRA Ltd's Q1 FY27 earnings call…
- Emkay Global Financial Services Ltd (Q1 FY27)
Consolidated revenue for Q1 FY27: INR 965 million, up 24% YoY (Page 9, 10, 27) . Key concall takeaways from Emkay Global Financial Services Ltd's Q1 FY27…
- Systematix Corporate Services Ltd (Q1 FY27)
Q1 FY27 consolidated total income from operations was ₹56.26 Cr (Page 12), compared to ₹39.17 Cr in Q1 FY26 (Page 11), indicating a significant year-on-year…
- Dam Capital Advisors Ltd (Q1 FY27)
Total income for Q1 FY27: ₹30.0 Cr, down 2.9% YoY (₹30.9 Cr in Q1 FY26) [Pages 3, 5, 6, 14] . Key concall takeaways from Dam Capital Advisors Ltd's Q1 FY27…
Frequently Asked Questions
What were CARE Ratings Ltd Q1 FY27 results?
Consolidated Operating Income for Q1 FY27: Rs. Standalone Q1 FY27: - Operating Income: Rs.
What is CARE Ratings Ltd share price analysis?
CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.
Is CARE Ratings Ltd planning capital expenditure?
The investor presentation does not mention any capex, capacity expansion, new plant, or project investments.
Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.